Hyperactivation of the HH pathway, either through deletion of PTCH1, mutational activation of SMO or overexpression of GLI1 or GLI2, has been reported in human and mouse BCC.3, 4, 24. This evidence concerns the gene SMO and skin basal cell carcinoma.